Shan Zhou1
Yong Li
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
- 1Section of Epidemiology and Population Science, Department of Medicine, Baylor College of Medicine, Houston, TX, United States
- 2The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Cancer Research Institute and School of Basic Medicine, Central South University, Changsha, China
- 3Hematopathology Division, Department of Pathology, Duke University Medical Center, Durham, NC, United States
A Corrigendum on
Clinical and immunological effects of p53-targeting vaccines
by Zhou S, Fan C, Zeng Z, Young KH and Li Y (2021). Front. Cell Dev. Biol. 9:762796. doi: 10.3389/fcell.2021.762796
In the published article, there was an error in Affiliations for Yong Li [1,2]. Instead of “[1,2],” it should be “[1]” (i.e., Yong Li is only affiliated with Baylor College of Medicine).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: p53, vaccine, Cancer, immunotherapy, T cell
Citation: Zhou S, Fan C, Zeng Z, Young KH and Li Y (2023) Corrigendum: Clinical and immunological effects of p53-targeting vaccines. Front. Cell Dev. Biol. 11:1267661. doi: 10.3389/fcell.2023.1267661
Received: 26 July 2023; Accepted: 27 July 2023;
Published: 02 August 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Zhou, Fan, Zeng, Young and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Yong Li, eW9uZy5saUBiY20uZWR1